Mar 07, 2018 21:06 pm UTC| Business
CHICAGO, March 07, 2018 -- Potbelly Corporation (NASDAQ:PBPB) today announced that Alan Johnson, President and Chief Executive Officer, and Michael Coyne, Senior Vice President and Chief Financial Officer, will...
OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2017 Financial Results
Mar 07, 2018 21:06 pm UTC| Business
WARSAW, Ind., March 07, 2018 -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today its financial results for the fourth quarter and full...
Crinetics Pharmaceuticals to Present at Cowen and Company 38th Annual Health Care Conference
Mar 07, 2018 21:06 pm UTC| Business
SAN DIEGO, March 07, 2018 -- Crinetics Pharmaceuticals, Inc., a rare disease therapeutics company focused on endocrine disorders and endocrine-related cancers, today announced that Scott Struthers, Ph.D., founder and...
XOMA Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update
Mar 07, 2018 21:06 pm UTC| Business
Transformed business model to a royalty aggregator with extensive asset portfolio and capital;Added nine new partner-funded programs in 2017 with potential for milestone and royalty payments;Current cash balance sufficient...
iPass to Present at the 30th Annual ROTH Conference
Mar 07, 2018 21:06 pm UTC| Business
REDWOOD SHORES, Calif., March 07, 2018 -- iPass Inc. (NASDAQ:IPAS), a leading provider of global mobile connectivity, announced Chief Executive Officer Gary Griffiths is scheduled to participate in a fireside chat at...
ZAGG Announces Executive Leadership Transition
Mar 07, 2018 21:06 pm UTC| Business
SALT LAKE CITY, March 07, 2018 -- ZAGG Inc (Nasdaq:ZAGG), a leading global mobile lifestyle company, announced today that Randy Hales will retire as ZAGG’s President and CEO after serving in the role for the past six...
Evoke Pharma Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Highlights
Mar 07, 2018 21:06 pm UTC| Business
Successfully completed pivotal pharmacokinetic trial and finalized the proposed to-be-marketed Gimoti™ doseAnnounced discovery of sex-based pharmacokinetic differences for Gimoti™Met with FDA regarding NDA women-only...